Clinical Efficacy and Changes of Urothelial Dysfunction after Repeated Detrusor Botulinum Toxin A Injections in Chronic Spinal Cord-Injured Bladder

Chornic spinal cord injury (SCI) will induce bladder urothelium dysfunction. This study investigated the therapeutic effects on urothelial dysfunction after repeated detrusor injections of onabotulinumtoxinA (BoNT-A) in SCI patients with neurogenic detrusor overactivity (NDO). Twenty chronic suprasa...

Full description

Bibliographic Details
Main Authors: Sheng-Fu Chen, Chia-Hwei Chang, Hann-Chorng Kuo
Format: Article
Language:English
Published: MDPI AG 2016-05-01
Series:Toxins
Subjects:
Online Access:http://www.mdpi.com/2072-6651/8/6/164
_version_ 1818038762996760576
author Sheng-Fu Chen
Chia-Hwei Chang
Hann-Chorng Kuo
author_facet Sheng-Fu Chen
Chia-Hwei Chang
Hann-Chorng Kuo
author_sort Sheng-Fu Chen
collection DOAJ
description Chornic spinal cord injury (SCI) will induce bladder urothelium dysfunction. This study investigated the therapeutic effects on urothelial dysfunction after repeated detrusor injections of onabotulinumtoxinA (BoNT-A) in SCI patients with neurogenic detrusor overactivity (NDO). Twenty chronic suprasacral SCI patients with NDO were enrolled. The patients received 300 U BoNT-A injection into the detrusor every six months. The urothelium was assessed by cystoscopic biopsy at baseline and six months after each BoNT-A treatment. Immunofluorescence staining for urothelial dysfunction, including E-cadherin, zonula occludens-1 (ZO-1), tryptase for mast cell activity, and urothelial apoptosis were investigated. The outcome of urothelial dysfunction parameters after BoNT-A injection were compared between baseline and six months after each treatment. Repeated 300 U BoNT-A injections showed a sustained decrease of detrusor pressure compared with baseline. After three repeated BoNT-A detrusor injections, significantly greater distributions of E-cadherin (p = 0.042) and ZO-1 (p = 0.003) expressions, but no significant changes, of urothelial apoptosis and mast cell activation were found after repeated BoNT-A therapy. Urothelial dysfunction, such as adhesive and junction protein concentrations in SCI patients’ bladders, recovered after three repeated cycles of BoNT-A treatment. The therapeutic effects sustained. However, urothelial inflammation and apoptosis after SCI were not significantly improved after three repeated BoNT-A injections.
first_indexed 2024-12-10T07:47:54Z
format Article
id doaj.art-790e4ce27ded4c13ab3a64c7741ec28d
institution Directory Open Access Journal
issn 2072-6651
language English
last_indexed 2024-12-10T07:47:54Z
publishDate 2016-05-01
publisher MDPI AG
record_format Article
series Toxins
spelling doaj.art-790e4ce27ded4c13ab3a64c7741ec28d2022-12-22T01:57:08ZengMDPI AGToxins2072-66512016-05-018616410.3390/toxins8060164toxins8060164Clinical Efficacy and Changes of Urothelial Dysfunction after Repeated Detrusor Botulinum Toxin A Injections in Chronic Spinal Cord-Injured BladderSheng-Fu Chen0Chia-Hwei Chang1Hann-Chorng Kuo2Department of Urology, Buddhist Tzu Chi General Hospital and Tzu Chi University, 707, Section 3, Chung Yang Road, Hualian 970, TaiwanDepartment of Urology, Buddhist Tzu Chi General Hospital and Tzu Chi University, 707, Section 3, Chung Yang Road, Hualian 970, TaiwanDepartment of Urology, Buddhist Tzu Chi General Hospital and Tzu Chi University, 707, Section 3, Chung Yang Road, Hualian 970, TaiwanChornic spinal cord injury (SCI) will induce bladder urothelium dysfunction. This study investigated the therapeutic effects on urothelial dysfunction after repeated detrusor injections of onabotulinumtoxinA (BoNT-A) in SCI patients with neurogenic detrusor overactivity (NDO). Twenty chronic suprasacral SCI patients with NDO were enrolled. The patients received 300 U BoNT-A injection into the detrusor every six months. The urothelium was assessed by cystoscopic biopsy at baseline and six months after each BoNT-A treatment. Immunofluorescence staining for urothelial dysfunction, including E-cadherin, zonula occludens-1 (ZO-1), tryptase for mast cell activity, and urothelial apoptosis were investigated. The outcome of urothelial dysfunction parameters after BoNT-A injection were compared between baseline and six months after each treatment. Repeated 300 U BoNT-A injections showed a sustained decrease of detrusor pressure compared with baseline. After three repeated BoNT-A detrusor injections, significantly greater distributions of E-cadherin (p = 0.042) and ZO-1 (p = 0.003) expressions, but no significant changes, of urothelial apoptosis and mast cell activation were found after repeated BoNT-A therapy. Urothelial dysfunction, such as adhesive and junction protein concentrations in SCI patients’ bladders, recovered after three repeated cycles of BoNT-A treatment. The therapeutic effects sustained. However, urothelial inflammation and apoptosis after SCI were not significantly improved after three repeated BoNT-A injections.http://www.mdpi.com/2072-6651/8/6/164botulinum toxin Aurothelial dysfunctionspinal cord injury
spellingShingle Sheng-Fu Chen
Chia-Hwei Chang
Hann-Chorng Kuo
Clinical Efficacy and Changes of Urothelial Dysfunction after Repeated Detrusor Botulinum Toxin A Injections in Chronic Spinal Cord-Injured Bladder
Toxins
botulinum toxin A
urothelial dysfunction
spinal cord injury
title Clinical Efficacy and Changes of Urothelial Dysfunction after Repeated Detrusor Botulinum Toxin A Injections in Chronic Spinal Cord-Injured Bladder
title_full Clinical Efficacy and Changes of Urothelial Dysfunction after Repeated Detrusor Botulinum Toxin A Injections in Chronic Spinal Cord-Injured Bladder
title_fullStr Clinical Efficacy and Changes of Urothelial Dysfunction after Repeated Detrusor Botulinum Toxin A Injections in Chronic Spinal Cord-Injured Bladder
title_full_unstemmed Clinical Efficacy and Changes of Urothelial Dysfunction after Repeated Detrusor Botulinum Toxin A Injections in Chronic Spinal Cord-Injured Bladder
title_short Clinical Efficacy and Changes of Urothelial Dysfunction after Repeated Detrusor Botulinum Toxin A Injections in Chronic Spinal Cord-Injured Bladder
title_sort clinical efficacy and changes of urothelial dysfunction after repeated detrusor botulinum toxin a injections in chronic spinal cord injured bladder
topic botulinum toxin A
urothelial dysfunction
spinal cord injury
url http://www.mdpi.com/2072-6651/8/6/164
work_keys_str_mv AT shengfuchen clinicalefficacyandchangesofurothelialdysfunctionafterrepeateddetrusorbotulinumtoxinainjectionsinchronicspinalcordinjuredbladder
AT chiahweichang clinicalefficacyandchangesofurothelialdysfunctionafterrepeateddetrusorbotulinumtoxinainjectionsinchronicspinalcordinjuredbladder
AT hannchorngkuo clinicalefficacyandchangesofurothelialdysfunctionafterrepeateddetrusorbotulinumtoxinainjectionsinchronicspinalcordinjuredbladder